CMS Belgium and CMS France advised Gryphon Investors on their acquisition of Metagenics

CMS Belgium and CMS France successfully advised, alongside Kirkland & Ellis, Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, on the Belgian and French aspects of Gryphon’s acquisition of Metagenics, Inc. from Alticor Inc. Metagenics is a leading global practitioner-recommended nutritional supplement company. 

The CMS team that advised Gryphon included Vincent Dirckx and Candice Kunkera (Corporate, Belgium), Benoît Vandervelde and Anaïs Casteur (Finance, Belgium) as well as Bruno Fonteyn (Health Regulatory), Sophie Berg, Océane De Ridder (Employment) and Stéphanie Houx (Tax) and Alexandre Morel, Martine Audran and Louise Paysant (Corporate, France), Jean-Baptiste Thiénot, Océane Chambrion (Health Regulatory), Anne-Laure Villedieu, Josephine Colin, Marie Semaan,  Benjamin Benezeth, and Pierre Fumery (Data Protection, France), Caroline Froger-Michon (Employment, France).